Company & Sponsor Intelligence
University of Wisconsin, Madison
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials2
Recruiting0
Completed2
Countries1
Therapeutic footprint
alzheimersanxiety
Indexed studies
NCT02989493Testing Doxazosin to Treat Stress Mechanisms in Alcoholism
anxiety · United StatesPHASE2
anxiety · United StatesPHASE2
NCT03117829Study: Diet and Exercise Study to Improve Brain Blood Flow: Blood Flow Improvement Trial
alzheimers · United StatesNA
alzheimers · United StatesNA
Intelligence layer updated: 2026-06-10 02:57:56.223123+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →